Just compare the last two PRs regarding NASH. The first had 5 initial patients and this one has 15. The fat reduction is still "up to 45%" - this means the additional 10 patients did not see higher than the 45% from the first 5. The fibrosis reduction in the first 5 was PRed at "up to 10%". Now with 15 they say "up to 8%". So judge for yourself, what is really this PR about?
Simple - NOTHING that would move the needle. This is just NP talking because he has a hole in his face. Let's see the vote result.
Currently there is no TREATMENT AT ALL FOR NASH other than LIVER TRANSPLANT. SO NO SOC hence Accerated approval. Arrowhead made a 1 billion partnership agreement for ARWR early clinical stage candidate.